Ontogeny of hepatic energy metabolism genes in mice as revealed by RNA-sequencing

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Renaud, Helen J ^a   Cui, Yue Julia ^a   Lu, Hong ^b   Zhong, Xiao Bo ^c   Klaassen, Curtis D ^d  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COA OXIDASE 1; ACYL COENZYME A DESATURASE; ACYL COENZYME A OXIDASE; CARNITINE PALMITOYLTRANSFERASE 1A; CARNITINE PALMITOYLTRANSFERASE I; ELONGATION OF VERY LONG CHAIN FATTY ACID LIKE 3; MESSENGER RNA; STEAROYL COA DESATURASE 1; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

ADULT; AGE DISTRIBUTION; ANIMAL TISSUE; ARTICLE; BILE ACID METABOLISM; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENERGY METABOLISM; FATTY ACID OXIDATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; GLYCOLYSIS; KETOGENESIS; LIPID METABOLISM; LIVER DEVELOPMENT; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONTOGENY; PERINATAL PERIOD; RNA SEQUENCE; WEANING; AGING; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; PHYSIOLOGY; SEQUENCE ANALYSIS;

AGING; ANIMALS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; LIVER; MALE; MICE; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA;

EID: 84905472515     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104560     Document Type: Article

References (39)

1. Casteels K, Mathieu C (2003) Diabetic ketoacidosis. Rev Endocr Metab Disord 4: 159-166. (Pubitemid 36547095)
2. Zammit VA (1996) Role of insulin in hepatic fatty acid partitioning: emerging concepts. Biochem J 314 (Pt 1): 1-14.
3. Zammit VA, Moir AM (1994) Monitoring the partitioning of hepatic fatty acids in vivo: keeping track of control. Trends Biochem Sci 19: 313-317. (Pubitemid 24259981)
4. Sommerfeld A, Krones-Herzig A, Herzig S (2011) Transcriptional co-factors and hepatic energy metabolism. Mol Cell Endocrinol 332: 21-31.
5. Herrera E, Amusquivar E (2000) Lipid metabolism in the fetus and the newborn. Diabetes Metab Res Rev 16: 202-210. (Pubitemid 30410276)
6. Girard J, Ferre P, Pegorier JP, Duee PH (1992) Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol Rev 72: 507-562.
7. Li T, Huang J, Jiang Y, Zeng Y, He F, et al. (2009) Multi-stage analysis of gene expression and transcription regulation in C57/B6 mouse liver development. Genomics 93: 235-242.
8. Gualdi R, Bossard P, Zheng M, Hamada Y, Coleman JR, et al. (1996) Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev 10: 1670-1682. (Pubitemid 26268871)
9. Jochheim A, Cieslak A, Hillemann T, Cantz T, Scharf J, et al. (2003) Multi-stage analysis of differential gene expression in BALB/C mouse liver development by high-density microarrays. Differentiation 71: 62-72. (Pubitemid 38230420)
10. Panadero M, Herrera E, Bocos C (2000) Peroxisome proliferator-activated receptor-alpha expression in rat liver during postnatal development. Biochimie 82: 723-726.
11. Serra D, Asins G, Hegardt FG (1993) Ketogenic mitochondrial 3-hydroxy 3-methylglutaryl-CoA synthase gene expression in intestine and liver of suckling rats. Arch Biochem Biophys 301: 445-448. (Pubitemid 23214144)
12. Yubero P, Hondares E, Carmona MC, Rossell M, Gonzalez FJ, et al. (2004) The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism. Endocrinology 145: 4268-4277. (Pubitemid 39120576)
13. Renaud HJ, Cui JY, Lu H, Klaassen CD (2014) Effect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver-insights into mechanisms of hepatic steatosis. PLoS One 9: e88584.
14. Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, et al. (2004) PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat Med 10: 530-534. (Pubitemid 38667913)
15. Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, et al. (2003) Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc Natl Acad Sci U S A 100: 4012-4017. (Pubitemid 36418148)
16. Lustig Y, Ruas JL, Estall JL, Lo JC, Devarakonda S, et al. (2011) Separation of the gluconeogenic and mitochondrial functions of PGC-1{alpha} through S6 kinase. Genes Dev 25: 1232-1244.
17. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, et al. (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464: 121-125.
18. Shimazu T, Hirschey MD, Hua L, Dittenhafer-Reed KE, Schwer B, et al. (2010) SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab 12: 654-661.
19. Jing E, Emanuelli B, Hirschey MD, Boucher J, Lee KY, et al. (2011) Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc Natl Acad Sci U S A 108: 14608-14613.
20. Hirschey MD, Shimazu T, Jing E, Grueter CA, Collins AM, et al. (2011) SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 44: 177-190.
21. Neuschwander-Tetri BA (2007) Fatty liver and the metabolic syndrome. Curr Opin Gastroenterol 23: 193-198.
22. Saadeh S (2007) Nonalcoholic Fatty liver disease and obesity. Nutr Clin Pract 22: 1-10.
23. Bell M, Wang H, Chen H, McLenithan JC, Gong DW, et al. (2008) Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance. Diabetes 57: 2037-2045.
24. McManaman JL, Bales ES, Orlicky DJ, Jackman M, MacLean PS, et al. (2013) Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease. J Lipid Res 54: 1346-1359.
25. Huyghe S, Casteels M, Janssen A, Meulders L, Mannaerts GP, et al. (2001) Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse. Biochem J 353: 673-680. (Pubitemid 32158336)
26. Thumelin S, Esser V, Charvy D, Kolodziej M, Zammit VA, et al. (1994) Expression of liver carnitine palmitoyltransferase I and II genes during development in the rat. Biochem J 300 (Pt 2): 583-587. (Pubitemid 24167921)
27. Decaux JF, Ferre P, Robin D, Robin P, Girard J (1988) Decreased hepatic fatty acid oxidation at weaning in the rat is not linked to a variation of malonyl-CoA concentration. J Biol Chem 263: 3284-3289. (Pubitemid 18072784)
28. Louet JF, Le May C, Pegorier JP, Decaux JF, Girard J (2001) Regulation of liver carnitine palmitoyltransferase I gene expression by hormones and fatty acids. Biochem Soc Trans 29: 310-316. (Pubitemid 32587523)
29. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, et al. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15: 3012-3022.
30. Zadravec D, Brolinson A, Fisher RM, Carneheim C, Csikasz RI, et al. (2010) Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. FASEB J 24: 4366-4377.
31. Jakobsson A, Jorgensen JA, Jacobsson A (2005) Differential regulation of fatty acid elongation enzymes in brown adipocytes implies a unique role for Elovl3 during increased fatty acid oxidation. Am J Physiol Endocrinol Metab 289: E517-526. (Pubitemid 41356071)
32. Jorgensen JA, Zadravec D, Jacobsson A (2007) Norepinephrine and rosiglitazone synergistically induce Elovl3 expression in brown adipocytes. Am J Physiol Endocrinol Metab 293: E1159-1168. (Pubitemid 350106581)
33. Anzulovich A, Mir A, Brewer M, Ferreyra G, Vinson C, et al. (2006) Elovl3: a model gene to dissect homeostatic links between the circadian clock and nutritional status. J Lipid Res 47: 2690-2700. (Pubitemid 44936082)
34. Brown JM, Rudel LL (2010) Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr Opin Lipidol 21: 192-197.
35. Miyazaki M, Dobrzyn A, Elias PM, Ntambi JM (2005) Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development. Proc Natl Acad Sci U S A 102: 12501-12506. (Pubitemid 41266388)
36. Mauvoisin D, Mounier C (2011) Hormonal and nutritional regulation of SCD1 gene expression. Biochimie 93: 78-86.
37. Zhang X, Liu J, Su W, Wu J, Wang C, et al. (2013) Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRalpha-SREBP1c-dependent mechanism. J Diabetes.
38. Cavender CP, Turley SD, Dietschy JM (1995) Sterol metabolism in fetal, newborn, and suckled lambs and their response to cholesterol after weaning. Am J Physiol 269: E331-340.
39. Goedeke L, Fernandez-Hernando C (2012) Regulation of cholesterol homeostasis. Cell Mol Life Sci 69: 915-930.